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Summary We report the case of a 7-year-old girl presenting with giant cell tumor (GCT) of the
index ﬁnger, complicated by lung metastases. Index disarticulation, pulmonary metastasectomy
and chemotherapy failed to produce a cure, and the child died at the age of 8 years after 1 year’s
evolution. The pulmonary metastases were discovered following hypoxia during initial biopsy.Lung metastasis;
Lethal complication
A review of the literature shows this observation to be original, in terms of the patient’s age
and of the location, onset and fatal outcome of metastasis. The hypoxic episode complicating
biopsy raises the issue of early screening for lung metastases in GCT. Pulmonary dissemination
of GCT is of severe prognosis.
© 2010 Elsevier Masson SAS. All rights reserved.
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iant cell tumor (GCT) usually concerns young adults and
resents as epiphyseal osteolytic long-bone tumor [1—3].
ung metastasis is a rare complication, with low associated
ortality [4,5]. We report a case of GCT in an 8-year-old
irl who died following respiratory distress caused by lung
etastasis. The case is original due not only to the patient’s
oung age but also to the GCT site on the distal phalanx of
he index ﬁnger with lung metastases discovered on biopsy
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oi:10.1016/j.otsr.2009.12.007f the primitive lesion. Varied chemotherapy was unable to
ontrol pulmonary dissemination.
bservation
7-year-old girl presented with inﬂammatory pain in the
ndex ﬁnger. X-ray found heterogeneous osteolysis of the
hird phalanx (P3) (Fig. 1). The bone was swollen, with cor-
ical lysis involving the growth cartilage.
MRI (Fig. 2) showed medullary replacement in iso-signal
ith respect to joint and conjunctive cartilage on the var-
ous sequences. Gadolinium injection sharply enhanced the
esion; there was also soft-tissue contrast uptake.
Surgical biopsy was prescribed, and was complicated by a
erioperative episode of hypoxia requiring prolonged oxygen
served.
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iFigure 1 Index ﬁnger X-ray: heterogeneous osteolysis of the
third phalanx.
therapy. Chest X-ray (Fig. 3) was performed immediately,
and found numerous bilateral parenchymatous pulmonary
nodules suggestive of multiple bilateral pulmonary metas-
tases. The hypoxia was controlled by nasal cannula oxygen
therapy at 2 l/min.
Anatomopathologic examination of the bone biopsy sam-
ple diagnosed cytologically benign giant-cell tumor (Fig. 4).
Extension was assessed: technetium 99 bone scan found a
single hyperﬁxation zone on P3 of the index. Chest MRI con-
ﬁrmed the presence of bilateral pulmonary nodules. PET
scan conﬁrmed metabolic hyperactivity in P3 and the two
pulmonary ﬁelds (Fig. 5).
Figure 2 MRI of lesion with Gadolinium injection: sharp
enhancement of lesion and neighboring soft tissue.
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sigure 3 Chest X-ray following biopsy: numerous bilateral
ulmonary parenchymatous nodules.
Pulmonary nodule biopsy by thoracotomy demonstrated
CT metastasis without malignancy criteria (Fig. 6).
hemotherapy was initiated, but the progression observed
n the inﬂammatory aspect of the primitive tumor led to
istal trans-interphalangeal disarticulation.
Analysis of the surgical sample conﬁrmed the initial diag-
osis, and the absence of any necrosis demonstrated the
nefﬁcacy of the chemotherapy. Although the cytological
nd architectural aspect was normal, there were numer-
us tumoral lymphatic emboli; the resection edges were
ealthy.
Histology of the primitive tumor and pulmonary metasta-
is biopsies was checked and conﬁrmed by the French Bone
athology Group (Groupe franc¸ais de pathologie osseuse
GFPO]).
Varied chemotherapy failed to prevent impairment of
espiratory function. The ﬁrst course associated etopo-
ide, carboplatin and biphosphonates, and the second
igure 4 Bone biopsy histology, with hematoxylin-phloxine-
affron (HPS) staining: numerous multinuclear giant cells.
312 S. Jacopin et al.
Figure 5 Chest PET-Scan: conﬁrming nodule met
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Tumoral lymphatic emboli, found in the present case, on theigure 6 Pulmonary nodule histology (HPS× 10): conﬁrming
iant cell tumor.
oxorubicin and gemcitabine. Both having failed, an anti-
ngiogenic association was tried: very small ‘‘metronomic’’
aily doses associating cyclophosphamide—celecoxib, then
toposide—celecoxib, provided only transitory respiratory
mprovement and were stopped; a palliative anti-EGFR mon-
clonal antibody/cetuximab treatment was ﬁnally given.
The patient died of acute respiratory distress 15 months
fter the primitive tumor biopsy.
iscussion
he present observation combines several points that are
nusual in bone GCT, with a hand locus in a child less than
0 years old, complicated by fatal lung metastasis: the case
s quite exceptional.
GCT usually occurs in young adults, generally in their
0s [1]; it is rarely found in the second decade and
ven more rarely before growth cartilage closure [2,3,6].
icci et al. [3], in a meta-analysis, found only 1.7% of
ases under the age of 15 years. When earlier than
one cartilage closure occurs, the tumor is located meta-
hyseally, generally respecting the physis [7,8]. GCT
enerally occurs in the long bones, especially distal femur
nd proximal tibia; the hand is rarely involved, with
o
[
aabolic hyperactivity in both pulmonary ﬁelds.
nly ﬁve out of 248 cases in one single-center series
1].
GCT is to be managed surgically. Resection may consist
n curettage or monoblock excision [6]. The almost com-
lete bone lysis found in the present case made curettage
mpossible and index disarticulation unacceptable without
istologic diagnosis. Simple biopsy was therefore initially
erformed.
Bone defect secondary to curettage can be treated by
utologous or synthetic bone graft [6].
Overall recurrence is about 30% [9], but higher in
ase of location in the hand [10]. Various adjuvant treat-
ents (acrylic cement [6], or phenolization and cryotherapy
11,12]) have been reported in an attempt to reduce recur-
ence, but their contribution is debatable: the quality of
he curettage or resection would seem rather to be the
etermining factor for recurrence [13].
Lung metastasis following GCT treatment has been known
or many years [14,15]. Such unfavorable evolution is rare
ut not unprecedented: Dominkus et al. [16] found a 2.1%
ate in a series of 649 GCTs, and Bertoni et al. [4] 7.2% in
series of 97. Extrapulmonary metastasis is extremely rare
8,17]. Lung metastasis secondary to GCT in a hand or foot
one is rare, with only two cases reported [18,19].
Unlike in the present case, lung metastasis is very rarely
iscovered during diagnosis of the initial GCT, but rather in
ase of recurrence, at a mean 2 to 3 years. Local recurrence
s indeed a known risk factor for lung metastasis, with a
ix-fold higher risk according to Rock [13].
We were surprised to discover lung metastases on
iopsy. The immediate postoperative respiratory distress
ight have been prevented if preoperative chest X-ray
ad been performed. Systematic preoperative chest X-
ay should perhaps be considered in case of bone lesion
iopsy suggestive of lung metastasis. Other than local
ecurrence, an analysis of the literature found several
ther lung metastasis risk factors in GCT: an aggressive
-ray aspect (Enneking grade 3) [4,16,20], Ki 67 anti-
en expression [21], and a distal radius location [22].ther hand, are non-predictive of generalized dissemination
4].
Although lung metastases tend to occur only some years
fter diagnosis [4,5], chest X-ray and CT scan should nev-
mor
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ertheless be performed as soon as diagnosis is conﬁrmed by
histology.
Lung metastases are usually excised [4,13,19]; where
surgery is unfeasible, chemotherapy is sometimes able to
control evolution [16], and comprises adriamycin, dacar-
bazine, vincristine, cytoxan, actinomycin, or bleomycin
[4,5,16]. Lung metastases may spontaneously evolve
towards necrosis or ossiﬁcation [23]. Radiotherapy [19] is
contraindicated due to the risk of induced malignancy.
Mortality associated with GCT lung metastasis ranges
from 0 to 40% according to the series: for 69 cases compiled
from the literature [4,5,16,19,21], there were six deaths:
i.e., 9% mortality. Death may be caused directly, as in the
present case of respiratory distress, or by massive hemop-
tysis, or else indirectly via chemotherapy side-effects such
as sepsis associated with agranulocytosis, or epistaxis with
associated coagulation disorder [4].
In conclusion, chest X-ray should be performed as of the
onset of GCT, whatever the aspect, location or patient’s
age. Prognosis in case of lung metastasis is reserved: where
surgery is not feasible, chemotherapy does not always suc-
ceed in preventing unfavorable evolution. The present case
conﬁrms the possibility of GCT occurring in a child before
growth cartilage closure.
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